Mankind Pharma - News
NSE: MANKIND | BSE: 543904
₹2,356.50
As on 01-Sep-2026IST
Market cap
₹97,273 Cr
Revenue (TTM)
₹14,738 Cr
P/E Ratio
47.6
P/B Ratio
5.8
Div. Yield
0 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsBoard Meeting Outcome for Dated August 26 2026
26-Aug-2026Intimation Regarding ESG Rating
22-Aug-2026No News & Announcements are available.